Skip to main content

Table 5 Univariate and multivariate of primary composite outcome

From: Urine albumin dipstick independently predicts cardiovascular and renal outcomes among rural Thai population: a 14-year retrospective cohort study

Baseline variables

Univariate

Multivariate

Crude HR (95%CI)

p-value

Adjusted HRa (95%CI)

p-value

Normoalbuminuria

Reference

1

Reference

1

Microalbuminuria

1.82 (1.15, 2.89)

0.011

1.4 (0.8, 2.44)

0.235

Macroalbuminuria

4.09 (2.12, 7.88)

< 0.001

3.13 (1.4, 6.96)

0.005

Age (years)

1.04 (1.02, 1.05)

< 0.001

1.02 (1, 1.05)

0.084

Male (%)

1.55 (1.02, 2.36)

0.04

1.26 (0.74, 2.15)

0.397

BMI (kg/m2)

1.02 (0.96, 1.08)

0.498

  

Systolic BP (mmHg)

1.01 (0.99, 1.02)

0.266

  

Diastolic BP (mmHg)

1 (0.98, 1.02)

0.867

  

History of Hypertension

3.26 (2.14, 4.95)

< 0.001

2.6 (1.35, 5)

0.004

History of Type2 DM

3.18 (1.95, 5.19)

< 0.001

1.64 (0.48, 5.66)

0.43

History of Dyslipidemia

1.6 (0.85, 3.02)

0.143

  

History of smoking (%)

1.33 (0.82, 2.16)

0.249

  

Serum creatinine (mg/dL)

3.85 (1.53, 9.68)

0.004

  

eGFR (ml/min/1.73m2)

0.98 (0.97, 0.99)

< 0.001

0.99 (0.98, 1.01)

0.365

Aspirin (use)

6.73 (4.33, 10.49)

< 0.001

5.28 (2.75, 10.14)

< 0.001

ACEI/ARBs (use)

2.86 (1.79, 4.57)

< 0.001

0.64 (0.32, 1.27)

0.204

Insulin (use)

5.67 (2.84, 11.31)

< 0.001

1.19 (0.42, 3.4)

0.738

Metformin (use)

2.41 (1.36, 4.28)

0.003

0.29 (0.09, 0.94)

0.038

  1. Primary composite outcome includes cardiovascular or renal morbidity and mortality
  2. BMI Body mass index, BP Blood pressure, DM Diabetes mellitus, eGFR Estimated glomerular filtration rate, ACEI/ARBs Angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers. All variables are at baseline level
  3. aAdjusted by age, gender, type 2 diabetes, hypertension, eGFR, Aspirin, ACEI/ARBs, Insulin and Metformin